4//SEC Filing
BLECH ISAAC 4
Accession 0000899243-19-007828
CIK 0001501697other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 9:35 PM ET
Size
5.9 KB
Accession
0000899243-19-007828
Insider Transaction Report
Form 4
BLECH ISAAC
Director
Transactions
- Award
Stock Option (right to buy)
2019-03-13+70,796→ 70,796 totalExercise: $6.84Exp: 2025-12-14→ Common Stock (70,796 underlying)
Footnotes (2)
- [F1]Fully vested.
- [F2]Reflects the Reporting Person's stock option to acquire 744,967 shares of X4 common stock for $0.65 per share that was assumed by the Issuer in the merger of Artemis AC Corp., a wholly-owned subsidiary of the Issuer, with and into X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) ("X4") on March 13, 2019 (the "Merger").
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0000905536
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 9:35 PM ET
- Size
- 5.9 KB